Galmed Pharmaceuticals Ltd. buy Stifel Nicolaus
Start price
21.02.24
/
50%
€0.34
Target price
21.02.25
€59.19
Performance (%)
-30.00%
Price
29.08.24
€0.24
Summary
This prediction is currently active. The price of Galmed Pharmaceuticals Ltd. has decreased since the start of the prediction. Compared to the start price this results in a performance of -30.00%. This prediction currently runs until 21.02.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | -11.852% | -11.852% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Stifel_Nicolaus for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Stifel Nicolaus from $61.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.38
08.05.24
08.05.24
€65.08
08.05.25
08.05.25
-36.70%
29.08.24
29.08.24